Chinese biotech says it will start first in vivo beta-thalassemia trial

Comments
Loading...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. I’m still recovering from yesterday, when Chicago was reportedly colder than Antarctica. I hope you’re all staying warm wherever you are. Let’s get into the news today.

Read the rest…

Market News and Data brought to you by Benzinga APIs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!